Blood levels of two markers may help predict treatment response and outcomes in pulmonary arterial hypertension patients, per ...

In 2019, while working on the second chapter of her thesis, Natasha discovered she was pregnant. Complications soon arose ...

Merck’s new pulmonary arterial hypertension (PAH) medication has posted another batch of promising clinical trial data, bolstering the company’s case that its first-in-class therapy ought to become a ...

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR).

A recent systematic review assessed the psychometric properties of various instruments for measuring QOL in patients with ...

Rising blood levels of an inflammatory marker, neutrophil-to-lymphocyte ratio, linked to poorer outcomes with chronic kidney ...

Tiprelestat was safe and well tolerated, with initial signs of clinical efficacyKiel, Germany, December 9, 2024 – tiakis Biotech AG, a ...

The Mini Nutritional Assessment was viable for assessing nutritional status and predicting mortality outcomes in patients ...

This difference becomes clear in pulmonary hypertension, in which only the lungs' blood vessels stiffen progressively, leading ... Researchers Identify Over 2,000 Genetic Signals Linked to Blood ...

Pulmonary hypertension (PH), a life-threatening condition, is commonly seen in patients with interstitial lung disease (ILD), ...

The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. The ...